Nijenhuis, Cynthia M.
Hellriegel, Edward
Beijnen, Jos H.
Hershock, Diane
Huitema, Alwin D. R.
Lucas, Luc
Mergui-Roelvink, Marja
Munteanu, Mihaela
Rabinovich-Guilatt, Laura
Robertson, Philmore Jr.
Rosing, Hilde
Spiegelstein, Ofer
Schellens, Jan H. M.
Article History
Received: 6 April 2016
Accepted: 12 May 2016
First Online: 25 May 2016
Compliance with ethical standards
: This study was conducted in full accordance with the International Conference on Harmonisation Good Clinical Practice Consolidated Guideline (E6) and any applicable national and local laws and regulations. Written informed consent was obtained from each patient before any study procedures or assessments were initiated. Potential conflicts of interest are as follows: CMN, JHB, ADRH, LL, MM-R, HR, and JHMS report employment from Netherlands Cancer Institute and research support from Teva Branded Pharmaceutical Products R&D during the conduction of the study; EH, LR-G, and PR Jr. report employment and stock options from Teva Branded Pharmaceutical Products R&D during the conduction of the study; OS and DH report employment from Teva Branded Pharmaceutical Products R&D during the conduction of the study; MM has nothing to disclose.